Taking Stock After Gene Patents Are Invalidated

Wednesday, March 31, 2010 - 00:14 in Mathematics & Economics

Many biotechnology stocks fell as investors struggled to understand the impact of a ruling that threw out parts of two gene patents and called into question thousands more.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net